Please Note: This trial is no longer enrolling new participants
A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III Trial of Alpha 1 - Antitrypsin (AAT) Combined with Corticosteroids vs Corticosteroids Alone for the Treatment of High Risk Acute Graft-versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplant
Protocol No. | CTO-BMTCTN1705 | Scope | National |
---|---|---|---|
Principal Investigator | Mittal, Varun | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase III |